lilly novo glp-1 pricing Eli vs Nordisk: The Battle for Obesity Drug Supremacy Lilly and Novo Cut GLP-1

How to measure success Weight on the scale is one metric, but not the only one

The convergence of oral bioavailability and multi-receptor agonism is redefining the landscape of obesity and diabetes therapeutics

GGT, Gamma-glutamyl transferase

Where the research should go next Key open questions include how much endogenous GLP1 increase is needed for sustained weight change, whether combinations of diet, prebiotics, probiotics and nutraceuticals can match injectable outcomes, and the longterm safety of such combinations

Insulin resistance, which both causes and is caused by visceral fat, creates a metabolic trap where the body preferentially stores energy as belly fat while struggling to release it

Learn more $50 off your first month of Alloy Weight Care for new customers